ADENOSCAN

This brand name is authorized in Spain, France, Hong Kong, Japan, United Kingdom

Active ingredients

The drug ADENOSCAN contains one active pharmaceutical ingredient (API):

1 Adenine Deoxy Nucleoside UNII K72T3FS567 - ADENOSINE

Adenosine is a purine nucleoside which is present in all cells of the body. Animal pharmacology studies have in several species shown that adenosine has a negative dromotropic effect on the atrioventricular (AV) node. Read about Adenine Deoxy Nucleoside

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ADENOSCAN Solution for infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01EB10	Adenosine	C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61732
Country: FR	Base de données publique des médicaments	Identifier(s): 61855583
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 47758
Country: HK	Department of Health Drug Office	Identifier(s): 43112
Country: JP	医薬品医療機器総合機構	Identifier(s): 7990402A1029